Core Viewpoint - Longbai Group's subsidiary, Baili Lian New Materials, is enhancing its capital strength and optimizing its financial structure by introducing strategic investors and implementing a capital increase to seize opportunities in the chloride titanium dioxide market [1][2]. Group 1: Company Overview - Baili Lian New Materials is recognized as a national high-tech enterprise with an annual production capacity of 400,000 tons of chloride titanium dioxide, making it the largest single-site production base in China [1]. - The company leads the industry in multiple dimensions, including scale, cost, technology, and market presence [1]. Group 2: Capital Increase Details - As of June 30, 2025, the audited equity of Baili Lian New Materials is approximately 412.75 million yuan [2]. - The pre-investment valuation of Baili Lian New Materials is approximately 437.04 million yuan, with strategic investors set to inject a total of 200 million yuan, acquiring a 31.40% stake post-investment [2]. - The capital increase will raise the registered capital from 170 million yuan to approximately 247.80 million yuan, while Longbai Group will retain a 68.60% ownership stake [2]. Group 3: Strategic Investors - The strategic investors include several financial asset management companies such as China Everbright Financial Asset Investment Co., CITIC Financial Asset Management Co., and others [3].
龙佰集团:佰利联新材料拟引入战略投资者并实施增资扩股